| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |